Please ensure Javascript is enabled for purposes of website accessibility

CVS Health Names New CFO

By Eric Volkman - May 18, 2021 at 5:53PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yet another veteran Aetna executive ascends to the top ranks of the pharmacy chain operator.

CVS Health (CVS 2.05%) will soon undergo a notable change in its C-suite. On Tuesday, the big pharmacy chain operator announced that it has appointed a new CFO. That incoming executive, Shawn Guertin, will take the reins effective Friday, May 28.

He replaces Eva Boratto, who is departing after 11 years with the company.

Guertin is no stranger to CVS Health. Prior to his appointment, he served as CFO for Aetna, the veteran insurance company CVS Health bought in late 2018 in a splashy $70 billion deal. Prior to that, he served as CFO and treasurer at Coventry Health Care, which was ultimately acquired by Aetna. 

According to his LinkedIn page, Guertin is also a member of the board of directors of employee benefits company TriNet and DaVita Kidney Care.

CVS Health COVID-19 testing site.

Image source: CVS Health.

Of his Aetna tenure, CVS Health said that "He was the architect of the company's finance strategy during a period of rapid growth and transformation."

"He helped Aetna enter new markets and grow through expansion and acquisitions and was a key leader in shaping and affecting the merger with CVS Health in 2018," the company added.

Guertin's appointment emphasizes the importance CVS Health is clearly placing on the insurance side of its business. The company's relatively new CEO, Karen Lynch, was previously Aetna's president.

For his labors, the new CFO will receive an annual base salary of $1.25 million, with a one-time signing bonus of $1 million. Guertin will also be eligible for equity awards and other salary bonuses.

CVS Health investors seem to be happy about the new hire. On Tuesday, the company's shares closed 4.8% higher, against the 0.9% dip of the S&P 500 index.

 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$106.39 (2.05%) $2.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.